Embedded Files
Save the date
Save the date
The SMB Subgroup on Pharmacometrics is launching a webinar series this Fall which will take place the second Tuesday of each month, September through November, 12pm-1pm ET. Presentations will cover both career guidance and scientific content.
We will also be hosting a virtual social on December 9, 12pm-1pm ET (more details TBA).
Webinar series
Webinar series
Date/time: Tuesday, September 9th, 2025 at 12:00-1:00pm ET
RSVP: To receive the Zoom meeting information, please RSVP via this form.
Speaker: Malidi Ahamadi (Head of Modeling & Simulation, Sanofi)
Title: Model-Informed Drug Development: Scientific Frontiers and Career Pathways in Pharmacometrics
Abstract: Model-Informed Drug Development (MIDD) has become a cornerstone of modern drug development, enabling more efficient and scientifically rigorous decision-making across discovery, development, and regulatory interactions. In this talk, I will highlight recent advances in MIDD, including applications in oncology, neuroscience, and emerging AI/ML approaches, as well as the global harmonization efforts reflected in the ICH M15 draft guidance. Alongside the scientific content, I will share insights from my own career journey—beginning in applied mathematics and progressing through academia, regulatory collaborations, and leadership in industry—to illustrate the diverse pathways available to early-career scientists in pharmacometrics. Emphasis will be placed on developing core skills, building interdisciplinary collaborations, and engaging with professional societies to grow as both scientists and leaders. The session will conclude with practical advice for navigating a career in pharmacometrics and a discussion of future opportunities for the field.
Malidi Ahamadi, PhD, is Head of Modeling & Simulation within Quantitative Pharmacology at Sanofi, where he oversees global M&S strategies spanning early development to lifecycle management. He has over 20 years of experience in quantitative sciences, with a career that bridges applied mathematics, academia, and pharmaceutical drug development. Dr. Ahamadi has played a leading role in advancing Model-Informed Drug Development (MIDD) initiatives, serving as Deputy Topic Lead and co-author of the recent ICH M15 draft guidance on general principles for MIDD. He has contributed extensively to regulatory and industry collaborations, including the FDA MIDD Paired Meeting Program, the Clinical Trials Transformation Initiative, and the Critical Path Institute’s Parkinson’s disease consortium. Beyond his scientific and regulatory leadership, Dr. Ahamadi is deeply committed to mentoring junior scientists and fostering interdisciplinary connections, serving on the Mathematical and Computational Sciences SIG Steering Committee and active member of Pharmacometrics Subgroup of the Society for Mathematical Biology.
Calendar
Calendar
Past events
Past events
2025 SMB Annual Meeting
Networking Social
The SMB Pharmacometrics Subgroup will be hosting a networking social on the evening of Sunday, July 13, 6-10pm, at Little Brick Cafe (https://littlebrick.ca/). We will be providing hors d'oeuvres and a s'mores station, and there will be a cash bar. We hope you can join us!
If you plan on attending, please RSVP here. We have booked the space to accommodate 60 people.
Mini-symposium
The subgroup will also be sponsoring a two part mini-symposium featuring six technical talks and an industry panel discussion.
Title: Quantitative Systems Pharmacology: Linking mathematical biology to model informed drug development (MIDD)
Description: Quantitative systems pharmacology (QSP) combines mathematical and computational modeling tools with mechanistic understanding of biology and pharmacology to guide drug discovery and development. QSP is used in the pharmaceutical industry to accelerate and de-risk drug discovery and development across multiple stages, from target discovery/validation to clinical trial design to lifecycle management. In recent years, QSP has been increasingly used in regulatory submissions for clinical trials across many therapeutic areas (PMID:34734497). In this session, speakers will present recent advances and perspectives in the field of QSP. This minisymposia will have two sessions. The first session will consist of four technical talks. The second session will be comprised of two technical talks and an industry panel discussion with prepared and audience-driven questions.
Organizers: Marissa Renardy (GSK), Kathryn Link (Pfizer)
Speakers and panelists: Olivia Walch (Arcascope), Christian Michael (University of Michigan), Kathryn Link (Pfizer), Farrah Sadre-Marandi (qPharmetra), Sarah Minucci (Certara), Morgan Craig (Universite de Montreal), Marissa Renardy (GSK)
For more information, see the conference listing here: Part 1, Part 2
Page updated
Google Sites
Report abuse